These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 27411697)

  • 21. Plasma glucose regulation and mortality in pima Indians.
    Kim NH; Pavkov ME; Looker HC; Nelson RG; Bennett PH; Hanson RL; Curtis JM; Sievers ML; Knowler WC
    Diabetes Care; 2008 Mar; 31(3):488-92. PubMed ID: 18071000
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The Da Qing IGT and Diabetes study].
    Ayame H
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():499-502. PubMed ID: 15779429
    [No Abstract]   [Full Text] [Related]  

  • 23. Progression from optimal blood glucose and pre-diabetes to type 2 diabetes in a high risk population with or without hypertension in Isfahan, Iran.
    Janghorbani M; Amini M
    Diabetes Res Clin Pract; 2015 Jun; 108(3):414-22. PubMed ID: 25814432
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomised controlled trial evaluating lifestyle interventions in people with impaired glucose tolerance.
    Oldroyd JC; Unwin NC; White M; Mathers JC; Alberti KG
    Diabetes Res Clin Pract; 2006 May; 72(2):117-27. PubMed ID: 16297488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypertriglyceridemia is associated with development of metabolic glucose disorders, irrespective of glucose and insulin levels: a 15-year follow-up study.
    Guerrero-Romero F; Rodríguez-Moran M
    Eur J Intern Med; 2014 Mar; 25(3):265-9. PubMed ID: 24507408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ten-year mortality and cardiovascular morbidity in the Finnish Diabetes Prevention Study--secondary analysis of the randomized trial.
    Uusitupa M; Peltonen M; Lindström J; Aunola S; Ilanne-Parikka P; Keinänen-Kiukaanniemi S; Valle TT; Eriksson JG; Tuomilehto J;
    PLoS One; 2009 May; 4(5):e5656. PubMed ID: 19479072
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Excess Mortality among Persons with Type 2 Diabetes.
    Tancredi M; Rosengren A; Svensson AM; Kosiborod M; Pivodic A; Gudbjörnsdottir S; Wedel H; Clements M; Dahlqvist S; Lind M
    N Engl J Med; 2015 Oct; 373(18):1720-32. PubMed ID: 26510021
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of youth-onset type 2 diabetes mellitus on incidence of end-stage renal disease and mortality in young and middle-aged Pima Indians.
    Pavkov ME; Bennett PH; Knowler WC; Krakoff J; Sievers ML; Nelson RG
    JAMA; 2006 Jul; 296(4):421-6. PubMed ID: 16868300
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Physical activity and cause-specific mortality in men with Type 2 diabetes/impaired glucose tolerance: evidence from the Whitehall study.
    Batty GD; Shipley MJ; Marmot M; Smith GD
    Diabet Med; 2002 Jul; 19(7):580-8. PubMed ID: 12099962
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sustained diabetes risk reduction after real life and primary health care setting implementation of the diabetes in Europe prevention using lifestyle, physical activity and nutritional intervention (DE-PLAN) project.
    Gilis-Januszewska A; Lindström J; Tuomilehto J; Piwońska-Solska B; Topór-Mądry R; Szybiński Z; Peltonen M; Schwarz PE; Windak A; Hubalewska-Dydejczyk A
    BMC Public Health; 2017 Feb; 17(1):198. PubMed ID: 28202029
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High incidence of Type 2 diabetes mellitus in South African Indians: a 10-year follow-up study.
    Motala AA; Pirie FJ; Gouws E; Amod A; Omar MA
    Diabet Med; 2003 Jan; 20(1):23-30. PubMed ID: 12519316
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development and validation of a risk-score model for subjects with impaired glucose tolerance for the assessment of the risk of type 2 diabetes mellitus-The STOP-NIDDM risk-score.
    Tuomilehto J; Lindström J; Hellmich M; Lehmacher W; Westermeier T; Evers T; Brückner A; Peltonen M; Qiao Q; Chiasson JL
    Diabetes Res Clin Pract; 2010 Feb; 87(2):267-74. PubMed ID: 20022651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progression to impaired glucose metabolism in first-degree relatives of patients with type 2 diabetes in Isfahan, Iran.
    Janghorbani M; Amini M
    Diabetes Metab Res Rev; 2009 Nov; 25(8):748-55. PubMed ID: 19862775
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term effects of a randomised trial of a 6-year lifestyle intervention in impaired glucose tolerance on diabetes-related microvascular complications: the China Da Qing Diabetes Prevention Outcome Study.
    Gong Q; Gregg EW; Wang J; An Y; Zhang P; Yang W; Li H; Li H; Jiang Y; Shuai Y; Zhang B; Zhang J; Gerzoff RB; Roglic G; Hu Y; Li G; Bennett PH
    Diabetologia; 2011 Feb; 54(2):300-7. PubMed ID: 21046360
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progression to impaired glucose tolerance or type 2 diabetes mellitus in polycystic ovary syndrome: a controlled follow-up study.
    Celik C; Tasdemir N; Abali R; Bastu E; Yilmaz M
    Fertil Steril; 2014 Apr; 101(4):1123-8.e1. PubMed ID: 24502891
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Voglibose for prevention of type 2 diabetes mellitus: a randomised, double-blind trial in Japanese individuals with impaired glucose tolerance.
    Kawamori R; Tajima N; Iwamoto Y; Kashiwagi A; Shimamoto K; Kaku K;
    Lancet; 2009 May; 373(9675):1607-14. PubMed ID: 19395079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glucose-lowering with exogenous insulin monotherapy in type 2 diabetes: dose association with all-cause mortality, cardiovascular events and cancer.
    Holden SE; Jenkins-Jones S; Morgan CL; Schernthaner G; Currie CJ
    Diabetes Obes Metab; 2015 Apr; 17(4):350-62. PubMed ID: 25399739
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prioritising prevention: implementation of IGT Care Call, a telephone based service for people at risk of developing type 2 diabetes.
    Savas LA; Grady K; Cotterill S; Summers L; Boaden R; Gibson JM
    Prim Care Diabetes; 2015 Feb; 9(1):3-8. PubMed ID: 25175562
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The risk of type 2 diabetes mellitus according to 2-h plasma glucose level: The Korean Genome and Epidemiology Study (KoGES).
    Park SK; Ryoo JH; Oh CM; Choi JM; Choi YJ; Lee KO; Jung JY
    Diabetes Res Clin Pract; 2018 Dec; 146():130-137. PubMed ID: 28951335
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence and predictors of type 2 diabetes among Koreans: A 12-year follow up of the Korean Genome and Epidemiology Study.
    Han SJ; Kim HJ; Kim DJ; Lee KW; Cho NH
    Diabetes Res Clin Pract; 2017 Jan; 123():173-180. PubMed ID: 28043048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.